|
Volumn 56, Issue 6, 2008, Pages 758-770
|
Cinnamyl derivatives: Synthesis and factor Xa (FXa) inhibitory activities
|
Author keywords
Anticoagulant; Cinnamyl derivative; Factor Xa (FXa) inhibitory activity
|
Indexed keywords
3 [3 [4 [1 (ACETIMIDOYL)PIPERIDIN 4 YLOXY]PHENYLAMINO] 1 PROPENYL]BENZAMIDINE;
BLOOD CLOTTING FACTOR 10A INHIBITOR;
CINNAMIC ACID DERIVATIVE;
N [3 [1 (TERT BUTOXYCARBONYL)PIPERIDIN 3 YLOXY]PHENYL] N [[3 (3 CYANOPHENYL) 2 PROPENYL]SULFAMOYL]ACETIC ACID;
N [4 [1 (ACETIMIDOYL)PIPERIDIN 4 YLOXY] 3 CARBAMOYLPHENYL] N [3 (3 AMIDINOPHENYL) 2 PROPENYL]SULFAMOYL]ACETIC ACIC;
N [4 [1 (ACETIMIDOYL)PIPERIDIN 4 YLOXY] 3 CHLOROPHENYL] N [3 (3 AMIDINOPHENYL) 2 PROPENYL]SULFAMOYL]ACETIC ACID;
N [4 [1 (ACETIMIDOYL)PIPERIDIN 4 YLOXY] 3 CHLOROPHENYL] N [[3 (3 AMIDINOPHENYL) 2 PROPENYL]SULFAMOYL]ACETIC ACID;
N [4 [1 (ACETIMIDOYL)PIPERIDIN 4 YLOXY]PHENYL] N [3 (3 AMIDINOPHENYL) 2 PROPENYL]ETHANESULFONAMIDE;
N [4 [1 (ACETIMIDOYL)PIPERIDIN 4 YLOXY]PHENYL] N [3 (3 AMIDINOPHENYL)PROPYL]ETHANESULFONAMIDE;
N [4 [1 (ACETIMIDOYL)PIPERIDIN 4 YLOXY]PHENYL] N [3 (3 FLUOROPHENYL) 2 PROPENYL]ETHANESULFONAMIDE;
N [4 [1 (ACETIMIDOYL)PIPERIDIN 4 YLOXY]PHENYL] N [[3 (3 AMIDINOPHENYL) 2 PROPENYL]SULFAMOYL]ACETIC ACID;
ANTICOAGULATION;
ARTICLE;
CONTROLLED STUDY;
DRUG POTENCY;
DRUG SAFETY;
DRUG SYNTHESIS;
HUMAN;
IC 50;
IN VITRO STUDY;
IN VIVO STUDY;
MALE;
NONHUMAN;
STRUCTURE ACTIVITY RELATION;
ANIMALS;
BLOOD COAGULATION;
CINNAMATES;
CRICETINAE;
FACTOR XA;
HUMANS;
INDICATORS AND REAGENTS;
MAGNETIC RESONANCE SPECTROSCOPY;
MALE;
MASS SPECTROMETRY;
TRYPSIN INHIBITORS;
|
EID: 45749086466
PISSN: 00092363
EISSN: 13475223
Source Type: Journal
DOI: 10.1248/cpb.56.758 Document Type: Article |
Times cited : (3)
|
References (22)
|